Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Adma Biologics Inc (NASDAQ: ADMA) was $18.68 for the day, down -3.66% from the previous closing price of $19.39. In other words, the price has decreased by -$3.66 from its previous closing price. On the day, 2.7 million shares were traded. ADMA stock price reached its highest trading level at $19.19 during the session, while it also had its lowest trading level at $18.02.
Ratios:
Our analysis of ADMA’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 43.03 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 40.19. For the most recent quarter (mrq), Quick Ratio is recorded 2.90 and its Current Ratio is at 5.97. In the meantime, Its Debt-to-Equity ratio is 0.24 whereas as Long-Term Debt/Eq ratio is at 0.23.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 19 ’25 when Grossman Adam S sold 21,000 shares for $18.92 per share. The transaction valued at 397,320 led to the insider holds 2,061,850 shares of the business.
Grossman Adam S bought 84,000 shares of ADMA for $1,571,640 on Mar 19 ’25. On Nov 22 ’24, another insider, Tade Brad L., who serves as the CFO and Treasurer of the company, sold 15,000 shares for $21.15 each. As a result, the insider received 317,250 and left with 199,433 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 4607366144 and an Enterprise Value of 4258416896. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 23.08, and their Forward P/E ratio for the next fiscal year is 18.93. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.76. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.41 while its Price-to-Book (P/B) ratio in mrq is 12.66. Its current Enterprise Value per Revenue stands at 9.986 whereas that against EBITDA is 28.963.
Stock Price History:
The Beta on a monthly basis for ADMA is 0.61, which has changed by 2.1029902 over the last 52 weeks, in comparison to a change of 0.028231144 over the same period for the S&P500. Over the past 52 weeks, ADMA has reached a high of $23.64, while it has fallen to a 52-week low of $5.89. The 50-Day Moving Average of the stock is 5.90%, while the 200-Day Moving Average is calculated to be 8.85%.
Shares Statistics:
ADMA traded an average of 2.84M shares per day over the past three months and 3154130 shares per day over the past ten days. A total of 236.62M shares are outstanding, with a floating share count of 229.31M. Insiders hold about 3.50% of the company’s shares, while institutions hold 86.23% stake in the company. Shares short for ADMA as of 1741910400 were 15069973 with a Short Ratio of 4.56, compared to 1739491200 on 13739629. Therefore, it implies a Short% of Shares Outstanding of 15069973 and a Short% of Float of 6.529999999999999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
